Verve Therapeutics, Inc. (13) | Uncategorized (3)
- Offer Letter, dated as of April 16, 2019, by and between the Registrant and Sekar Kathiresan, M.D (Filed With SEC on May 28, 2021)
- Offer Letter, dated as of July 26, 2019, by and between the Registrant and Andrew Ashe, J.D (Filed With SEC on May 28, 2021)
- Offer Letter, dated as of July 26, 2019, by and between the Registrant and Andrew Bellinger, M.D., Ph.D (Filed With SEC on May 28, 2021)
